The NHMRC Research Translation Strategy 2026–2030 has been released, providing a strong national framework to accelerate the translation of health and medical research into improved health outcomes, stronger health systems and greater benefit for Australian communities.
The Australian Health Research Alliance (AHRA) has welcomed the Strategy, highlighting its importance in strengthening the impact of health and medical research across Australia.
The Strategy recognises the important role of Research Translation Centres (RTCs) in bridging the gap between research discovery and implementation, and includes a renewed focus on place‑based research and translation. This includes the importance of further investment to advance Aboriginal and Torres Strait Islander‑led research and rural, regional and remote (RRR) research.
Key priorities outlined in the Strategy include:
- Strengthening partnerships between researchers, health services, policymakers, consumers and industry to ensure research addresses real-world health challenges and can be translated into practice.
- Increased capability for impactful research translation and commercialisation, including developing the skills, systems and collaborative teams needed to move discoveries into implementation and scale.
- Equitable, high-quality, outcomes-focused and accessible research for public benefit, ensuring the benefits of research reach all Australians and support high-quality, evidence-based care across diverse communities.
As part of AHRA’s national network of NHMRC‑accredited Research Translation Centres, MACH supports the Strategy and its strong alignment with our work to connect research with real‑world healthcare challenges.
Read AHRA’s response to the Strategy: https://ahra.org.au/2026/07/16/australian-health-research-alliance-ahra-welcomes-nhmrc-research-translation-strategy-2026-2030-and-strengthened-support-for-research-translation-centres/